To assess the influence of these factors on increased cMP, PMP, and EMP (CD31+ CD41−) levels in AF patients, we evaluated each of these parameters in AF patients compared between the presence or absence of each cardiovascular risk factor and antithrombotic drugs. Here, PECAM1 is linked to atrial fibrillation.